Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance®) in type 2 diabetes

Garber, A;Cornes, M;Lehert, Philippe;Howlett, H.;Marre, M.
(2003) Diabetes, Obesity and Metabolism — Vol. 5, p. 171-179 (2003)

Files

No attached file found for this publication.

Details

Authors
  • Garber, A
    Author
  • Cornes, M
    Author
  • Lehert, Philippeorcid-logoFUCaM
    Author
  • Howlett, H.
    Author
  • Marre, M.
    Author
Abstract
(en) Meta-analysis of Double Blind randomized controlled trials on fixed combination Glibenclamide-Metformine (Glucovance) and proposal of a clinical compromise between minimzation of glycemy (hba1c) and BMI reduction.
Affiliations
  • Louvain School of Management

Citations

  • APA
  • Chicago
  • FWB

Garber, A., Cornes, M., Lehert, P., Howlett, H., & Marre, M. (2003). Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance®) in type 2 diabetes. Diabetes, Obesity and Metabolism, 5, 171-179. https://doi.org/10.1046/j.1463-1326.2003.00259.x (Original work published 2003)